Cruciferous Complete

by SP Standard Process · capsule · 90 capsules

  • Off the market since August 2025 (NIH)
  • UPC 8 12122 01065 8
  • DSLD label 256496
  • Serving 1 capsule
  • 90 servings

Cruciferous Complete by SP Standard Process lists 4 ingredients, 2 with an amount per serving of 1 capsule, such as 4 mcg of vitamin K and 10 mg of potassium; 2 sit inside a blend without their own amounts. Its current label entered the NIH Dietary Supplement Label Database on November 19, 2021.

What is in Cruciferous Complete?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Cruciferous Complete: Supplement Facts rows against the market (DSLD label 256496, January 2026 release)
IngredientAmount% DVAmong products listing it
Calories3 Calories
Vitamin K4 mcg4%Vitamin K in Cruciferous Complete against 4,607 products4 mcg per serving; the middle half of products list 35 mcg to 100 mcg, the median 80 mcg.DV 120 mcg4 mcg

99% of 4,607 products listing vitamin K give more (median 80 mcg).

Potassium10 mg1%Potassium in Cruciferous Complete against 11,614 products10 mg per serving; the middle half of products list 50 mg to 190 mg, the median 99 mg.DV 4,700 mg10 mg

93% of 11,614 products listing potassium give more (median 99 mg).

Proprietary Blend500 mg
Kalein the blend, no amount given
Brussels Sproutsin the blend, no amount given

Source: NIH ODS Dietary Supplement Label Database, label 256496 (entered November 19, 2021), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

The rows in the top or bottom tenth of the products that list the same ingredient, and any above the adult upper limit at the most servings a day the directions give:

  • 99% of the 4,607 products that print an amount of vitamin K list more than its 4 mcg of vitamin K (median 80 mcg).
  • 93% of the 11,614 products that print an amount of potassium list more than its 10 mg of potassium (median 99 mg).

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested Use: One capsule per day, or as directed.
Warnings
Caution: This product is processed in a facility that manufactures other products containing soy, milk, egg, wheat, peanut, tree nuts, fish, and shellfish.
Allergens and what it does not contain
GF Gluten-free

Source: label statements in DSLD label 256496.

What else is on the label?

Other ingredients: Gelatin, Water, Calcium Stearate.

How many labels does Cruciferous Complete have?

One label is on file, entered on November 19, 2021.

  1. Label 256496 (current) Entered November 19, 2021 · off the market August 15, 2025 · 90 capsules · UPC 8 12122 01065 8

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Standard Process Inc. (manufacturer), Palmyra, WI. All SP Standard Process products.

Where next?